Lab at Home

On-demand, at-home detection of biochemical health markers to
enable diagnostics.

Join Program

OVERVIEW

Telehealth is now widespread, but most routine testing still requires visits to a clinic or lab. This program is developing disruptive platform technologies to collect and analyze biological samples at home. This technology could revolutionize diagnostics, chronic disease management, and even clinical research, providing better access to care and a more disaster-resilient health care system.

PARTNERS

Companies we have partnered with on this program to date

Proactive Diagnostics

EnLiSense

Rizlab Health

Stanford

DNA Medicine Institute

APPROACH

Support the development and validation of new platform technologies for simple, rapid multiplexed analysis of biological specimens in the home setting.

These novel technologies:

Use non-invasive and minimally invasive samples to provide quantitative information about a patient's health status
Are readily adaptable to a broad menu of test panels to cover a wide range of disease states as well as standard health assessments
Offer rapid results for interpretation by health care providers